ARGENX SE revenue breakdown overview

ARGENX SE revenue for the last year amounted to 2.16 B EUR, the most of which — 2.02 B EUR — came from its highest performing source at the moment, Antibody-based Medicines, the year earlier bringing 1.13 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought ARGENX SE 1.75 B EUR, and the year before that — 995.82 M EUR.